ArticleFrontiers in immunology2022

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.

Qingya Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.